Saturday, October 05, 2024 3:02:13 PM
Investor082,
You’re posting nonsense and distorting reality. BP is involved as their FDA approved products are in clinical trials with TWO distinct DC technologies owned by NWBO. Those combo trials have only recently reached PII and their data are beginning to emerge now.
It’s better to stick with verifiable facts and reliable sources. We don’t want to hear defamatory baseless rumors.
Specifically, we want to hear what the clinical data say, what independent peer-reviewers say about those data, and what government regulators have to say.
Speculation on a message board is fine of course, but the discussion should be based on factual information, verifiable evidence, and credible full-context sources.
https://nwbio.com/audio-of-nwbio-2023-annual-shareholders-meeting/
https://www.nature.com/articles/s41467-024-48073-y
https://thejns.org/caselessons/downloadpdf/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.pdf
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175185151
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175149927
You’re posting nonsense and distorting reality. BP is involved as their FDA approved products are in clinical trials with TWO distinct DC technologies owned by NWBO. Those combo trials have only recently reached PII and their data are beginning to emerge now.
It’s better to stick with verifiable facts and reliable sources. We don’t want to hear defamatory baseless rumors.
Specifically, we want to hear what the clinical data say, what independent peer-reviewers say about those data, and what government regulators have to say.
Speculation on a message board is fine of course, but the discussion should be based on factual information, verifiable evidence, and credible full-context sources.
https://nwbio.com/audio-of-nwbio-2023-annual-shareholders-meeting/
https://www.nature.com/articles/s41467-024-48073-y
https://thejns.org/caselessons/downloadpdf/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.pdf
https://jamanetwork.com/journals/jamaoncology/fullarticle/2798847
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175185151
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175149927
Bullish
Believe carefully. This is the greatest and most powerful lesson that I have learned since arriving on Earth. Examine what you believe about yourself most importantly, and then believe carefully as you interact with the world.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
